.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Federal Trade Commission
Julphar
Farmers Insurance
Deloitte
Moodys
Merck
US Army
Medtronic
Fish and Richardson

Generated: June 25, 2017

DrugPatentWatch Database Preview

XENON XE 133 Drug Profile

« Back to Dashboard

What is the patent landscape for Xenon Xe 133, and what generic Xenon Xe 133 alternatives are available?

Xenon Xe 133 is a drug marketed by Mallinkrodt Nuclear, Gen Electric, Ge Healthcare, and Lantheus Medcl. and is included in six NDAs.

The generic ingredient in XENON XE 133 is xenon xe-133. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the xenon xe-133 profile page.

Summary for Tradename: XENON XE 133

Patents:0
Applicants:4
NDAs:6
Suppliers / Packagers: see list2
Clinical Trials: see list120
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:XENON XE 133 at DailyMed

Pharmacology for Tradename: XENON XE 133

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinkrodt Nuclear
XENON XE 133
xenon xe-133
GAS;INHALATION018327-001Mar 9, 1982RXNoNo► Subscribe► Subscribe
Lantheus Medcl
XENON XE 133
xenon xe-133
INJECTABLE;INJECTION017283-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Gen Electric
XENON XE 133
xenon xe-133
GAS;INHALATION017550-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Ge Healthcare
XENON XE 133-V.S.S.
xenon xe-133
GAS;INHALATION017687-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Lantheus Medcl
XENON XE 133
xenon xe-133
GAS;INHALATION017284-001Approved Prior to Jan 1, 1982RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
US Army
Accenture
Queensland Health
Novartis
Colorcon
Covington
Boehringer Ingelheim
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot